POPULARITY
Co-founders of VezoPay, Jake Pinkus and Lawrence Baker on how VezoPay smart rings work and future of payment methods, following the launched of Africa's first bright payment ring, beating tech giants like Samsung and Apple to the market. The VezoPay ring offers a contactless payment solution without needing wallets or phones.See omnystudio.com/listener for privacy information.
A new smart payment ring has been launched in South Africa – and it's built by South Africans for South Africans. In this episode of the TechCentral Show (TCS), TechCentral editor Duncan McLeod chats to VezoPay founders Jake Pinkus and Lawrence Baker about the launch of the ring – it's available in three variants at launch – and what was behind the idea. In the interview, they not only explain why they decided to build a payment ring, but also why they're entering what could soon become a highly competitive market globally, with both Samsung Electronics and Apple expected to launch their own smart rings later this year. Pinkus and Lawrence unpack: • How long they've been working on the payment ring, and where the idea came from; • How much research and development was involved, and who's backing the innovation; • How the technology works, and what exactly is inside the ring; • The various options available at launch; • How it works without having to be charged; • How the security features work (without giving the game away); • How VezoPay is working with South African banks; • Whether the ring can be used for ticketing (concerts, Gautrain, etc); • How much it costs; • The potential competition from Samsung and Apple; and • VezoPay's plans to expand beyond South Africa's borders. Don't miss the interview! TechCentral
Listen in as our Associate Pastor continues in our Romans series in chapter 8.
Luke 10:25-37
Matthew 28:19-20
Psalm 139:17-17
Romans 5:12-21
The post God's Love Language| Jeremiah 7:21-26| Pastor Lawrence Baker Sr. appeared first on Faith Community Bible Church.
The post Knowing God Personally | Pastor Lawrence Baker | January 1, 2023 appeared first on Faith Community Bible Church.
The post The Self-Reliant Church (The Church of Laodicea)| Revelation 3:14-18| Pastor Lawrence Baker, Sr. appeared first on Faith Community Bible Church.
The post The Danger of Distractions | Revelation 2.12-17 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
In this episode Taylor talks about the implications of the weird game between the Indianapolis Colts & Denver Broncosand what it means for both teams. Then he talks about his takeaways from some of the week four NFL games he watched including the Philadelphia Eagles outmuscling the Jacksonville Jaguars, Kyler Murray in the Arizona Cardinals versus Baker Mayfield and the Carolina Panthers and finally thr Los Angeles Chargers outlasting the Houston Texans
This week Drew sits down with fellow baller Lawrence Baker! Hear LB's story about growing up in Detriot never playing High School ball but getting a scholarship to play at IUP after winning a dunk contest. He's been everywhere from Europe to the Pittsburgh's ABA team the Yellowjackets during his career as well. The guys also college life and their love lives so I promise you're in for a trip.Tap In and make sure to follow us everywhere!
The post Stories|Pastor Michael Byrd|Pastor Lawrence Baker appeared first on Faith Community Bible Church.
The post Please and Thank You | Romans 1.16-17 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
The post A Heart After God | Psalm 51:1-19 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
The post The Pursuit of Happiness | Psalm 1:1-9 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
The post Missional Mandate | 1 Peter 4 :1-12 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
The post Living The Best Version Of Yourself | Pastor Lawrence Baker | Ephesians 4: 17-32 appeared first on Faith Community Bible Church.
The post “A Prayer For Unity” | Ephesians 3: 14-21 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
LIVE THURSDAYS at 9PM EST / 6PM PST! Sub on Youtube https://bit.ly/3pYAexO Follow on Twitch https://www.twitch.tv/frontlinegaming_tv Like us on Facebook https://www.facebook.com/FrontlineGaming Or listen wherever quality podcasts are found! Allan's still not yet a dad and so he's coming back out for another thirst quenching thirsty Thursday. Meanwhile in Gibraltar, Mani Cheema chants “u wot m8” while the world wonders if Lawrence Baker is meta enough for this jelly. Plus some other events too! All that and more, on the Thursday Show. Host: Paul Murphy Twitter: @warmaster_tpm Instagram: fightswithdice Forge The Narrative Podcast Co-Hosts: Adam Camilleri Art of War Downunder Podcast Alan “Pajama Pants” Bajramovic Gentlemen Gaming Podcast on Facebook. Produced by: Richard Hughes Edited by: The Ghost of Val Heffelfinger Special thanks to: Kelsey Grammer
The post Church | Revelations 2: 1-7 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
The post Understanding Faith | Hebrew 11: 1-6 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
The post Surviving Trauma | 2 Corinthians 12: 7-10 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
Steve speaks with Miniwargaming Dave. He runs the biggest 40k battle report channel in the world, he's written a book, made fantasy movies, won a business award and his next project is even bigger!! In this episode we talk about how it all started and what Lawrence Baker and Winters SEO did to inspire him. Vist Miniwargaming or see them on youtube. Check out Killteam: Pariah box at the Frontline Gaming Store. Like 40k Game Changers on Facebook Hear all the episodes at 40kgamechangers.com Theme music: "The Complex" by Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 4.0 License http://creativecommons.org/licenses/by/4.0/ Learn more about your ad choices. Visit megaphone.fm/adchoices
Today we celebrate the man who introduced Europe to the Piggyback Plant - it’s now a popular houseplant. We'll also learn about the man who was an early evangelist for gardening and working with Mother Nature. We hear an excerpt from a book by a celebrated plantsman as he discusses a beloved snow gum tree. We Grow That Garden Library™ with a joyful book about permaculture. And then we’ll wrap things up with the colorful story about the Indiana State Flower and how the Zinnia lost to the Peony. Subscribe Apple | Google | Spotify | Stitcher | iHeart To listen to the show while you're at home, just ask Alexa or Google to “Play the latest episode of The Daily Gardener Podcast.” And she will. It's just that easy. The Daily Gardener Friday Newsletter Sign up for the FREE Friday Newsletter featuring: A personal update from me Garden-related items for your calendar The Grow That Garden Library™ featured books for the week Gardener gift ideas Garden-inspired recipes Exclusive updates regarding the show Plus, each week, one lucky subscriber wins a book from the Grow That Garden Library™ bookshelf. Gardener Greetings Send your garden pics, stories, birthday wishes, and so forth to Jennifer@theDailyGardener.org Curated News Designing a Pollinator Habitat: Four Things to Consider | Story | The Xerces Society Facebook Group If you'd like to check out my curated news articles and original blog posts for yourself, you're in luck. I share all of it with the Listener Community in the Free Facebook Group - The Daily Gardener Community. So, there’s no need to take notes or search for links. The next time you're on Facebook, search for Daily Gardener Community, where you’d search for a friend... and request to join. I'd love to meet you in the group. Important Events March 15, 1754 Today is the birthday of the Scottish surgeon, botanist, and naturalist Archibald Menzies. Now there's a famous story about Archibald that goes something like this: One time, Joseph Banks sent Archibald on an expedition. At some point, Joseph ended up dining with the leadership of the country of Chile. Archibald was served nuts from the Chilean Pine Tree during the meal, and these nuts were featured as part of an elaborate dessert for this grand meal that Archibald enjoyed. As Archibald is sitting there, he begins to eat some of these nuts. But then, his inner-botanist took over, and Archibald realized that the nuts were actually large seeds. And so, Archibald does what any good botanist would do: he tucks five of the nuts in his pocket. And then, on his way back to England, Archibald planted the five seeds and started growing the Chilean Pine Tree right there on the ship. And guess what? He ended up growing them successfully. Now, once these trees started growing in England, they became known by a new common name when people started calling them the Monkey Puzzle Tree - because someone remarked that even a monkey would not be able to climb the Chilean Pine Tree. And as a result of this, Archibald became known as the Monkey Puzzle Man. Now today, sadly, Monkey Puzzle Trees are considered endangered. But like Archibald, gardeners still attempt to grow these curious trees from seed, and if you're fortunate, you can find those seeds online. Now another plant that Archibald discovered is the Piggyback Plant. Today, this is a popular houseplant, and its botanical name is Tolmiea menziesii in honor of Archibald Menzies. You may be wondering how it got the common name, the Piggyback Plant, which I think is an adorable name that is inspired by the way this plant grows. It turns out that Piggyback Plants develop buds at the base of each leaf where it meets the stalk. Then the new plants basically piggyback off the parent leaf, which forces the stem to bend down to the ground under the weight of that new plant, and the new baby Piggyback Plant can take off from there. Now because of its growing habit, Piggyback Plants are perfect for hanging baskets. And they really do make excellent houseplants because they like indirect light and partial shade. Online, I noticed that the Piggyback Plant is compared to the Strawberry Begonia because they both have attractive foliage, and they are super easy to propagate - which makes them a double win in my book. Anyway, happy heavenly birthday to Archibald Menzies - and thank you for the Monkey Puzzle Tree and the Piggyback Plant. March 15, 1858 Today is the birthday of the American horticulturist and botanist who co-founded the American Society for Horticultural Science, Liberty, Hyde Bailey, who was born on this day, March 15th in 1858. We owe a huge debt of gratitude to Liberty Hyde Bailey. He is responsible for starting so many things, including the 4-H movement, the nature study movement, parcel post, and even making sure that electricity got into rural parts of America. He truly was a pioneer. Looking back, it's actually rather staggering to reflect on Liberty Hyde Bailey’s work. Luckily for us, we’re able to get a clear picture of his activity because he was such an excellent writer. Liberty had some tremendous mentors in his life. First, he served as a research assistant to the great Asa Gray at Harvard in his herbarium, and he worked with Asa for over two years. Between being at Harvard and regularly working with Asa, he got the finest horticultural education and experience that a person could get in the late 1800s in the United States. After Harvard, Liberty went on to work in New York. Specifically, he served as the Department Chair for Horticulture at Cornell University. And if you recall studying genetics, learning about DNA, genes, and Mendel in middle school, that is due to Liberty Hyde Bailey. This is because Liberty evaluated what Mendel had done, and he realized that it was genuinely revolutionary work. Essentially, Liberty plucks Mendel out of obscurity and puts him in a place of honor - a spot Mendel so clearly deserved. Now, if you're having trouble remembering what Mendel accomplished, here’s a quick little primer. Mendel discovered the basic principles of heredity, and he did that by working with peas in his garden at an Augustinian monastery in Burno, in the Czech Republic. Over the course of seven years, Mendel grew nearly 30,000 pea plants. As he grew the peas, he documented everything about them - jotting notes about their height and shape and color, and all of this work resulted in what we now know as the laws of heredity. In fact, it was actually Mendel who came up with the genetic terms and the terminology that we still use today - like dominant and recessive genes. Mendel is a fascinating person to talk about with kids who are interested in gardening because he really was, at heart, a gardener. Mendel grew so many plants and took such pains to document everything about them; that’s a great story to share with any young gardeners that you may be working with this year. Anyway, back to Liberty Hyde Bailey. There was an excellent book that was written in 2019 that revived Liberty’s best essays, and it was edited by two men named John: John Stepien and John Linstrom. These two men pulled together Liberty’s writings which reveal a man who was a passionate evangelist for gardening. Indeed, Liberty loved gardening, and he wanted everyone else to love gardening, too. In fact, one of his famous quotes is that “Every family can have a garden.” This quote reminds me of the little phrase from the movie Ratatouille, “Everyone can cook.” Now, before I share a few more of Liberty's great quotes, I just wanted to read to you what the publisher said about Liberty's work. “Liberty Hyde Bailey built a reputation as the father of modern horticulture. And an evangelist for what he called the “garden sentiment,” the desire to raise plants from the good earth for the sheer joy of it, and for the love of the plants themselves.” Here are a few wonderful garden quotes that Liberty wrote. “If a person cannot love a plant after he has pruned it, then he's either done a poor job or is devoid of emotion.” And here's one of my favorites. "A person cannot love a plant after he has pruned it, then he has either done a poor job or is devoid of emotion." When I read that quote, it reminded me of my relationship with Creeping Charlie. A few summers ago, it was driving me crazy, and then I found a way to change my mindset around it - kind of like the way I ended up making peace with the rabbits in my garden. Somehow, I managed to reframe my thinking around Creeping Charlie, and I really think it all boiled down to learning about its medicinal qualities and how it was used and valued in gardens in the 1700s and 1800s. Now, I have one more additional quote by Liberty Hyde Bailey that I thought would be a great one to wrap up the segment on botanical history today, and it's a little verse that he wrote about spring. Yesterday the twig was brown and bare; Today the glint of green is there; Tomorrow will be leaflets spare; I know no thing so wondrous fair, No miracle so strangely rare. I wonder what will next be there! Unearthed Words One of my favorite trees in the Hillier Gardens and also popular with visitors, especially children, was the snow gum from the Australian Alps of New South Wales. Planted small from a pot in 1962, it had achieved a height of around 19 feet with several branches but had a distinct lean, enabling small children to sit astride its lower stem. Its exfoliating bark exhibited several shades of green, creamy-white, and silvery-gray, which I used to liken to the skin of a python. It was also solid and cool to the cheek, especially so on a hot summer's day. On one occasion, I introduced a group of partially-sighted visitors to this tree, encouraging them to stroke or hug the stem and to listen to the sound of the scimitar-shaped, leathery leaves shaking in the breeze. It was a special moment for them and me. Nearby grew a tall-stemmed Apache pine... The pine is today [a champion tree] while the snow gum, despite being supported, eventually blew down in a gale. — Roy Lancaster, My Life with Plants, Chapter: Spreading My Wings Grow That Garden Library Gaia's Garden by Toby Hemenway This book came out in 2009, and the subtitle is A Guide to Home-Scale Permaculture. Now, this book is one of my favorites. It truly is a garden classic, and I think it belongs in every Gardner's home library. Today most of us have had a decent amount of exposure to permaculture. But back in 2009, it still was a novel topic for many gardeners. Now the principle that is underlying every page of Gaia's garden is this: working with nature and not against her results in more beautiful, abundant, and forgiving gardens. I remember thinking the first time I read this book that Toby is such a joyful gardener - and this comes through on every page. That's why this book still remains a book that I recommend to beginning gardeners - as well as established gardeners — looking to refine and hone their gardening skills. Gaia's Garden shares everything you need to know to create a beautiful backyard ecosystem. And if you started gardening in 2020 during the pandemic, and you'd like to learn more about permaculture, Toby's book is a must-have. And I just have to share that one of my favorite garden experts, Robert Kourik, said this about Toby's book, “Permaculture gardens are no longer a thing of the future. They are here to stay and flourish. Gaia's Garden is enlightening and required reading for all people who desire to make their home landscape healthy, sustainable, and healing — and that perfectly encapsulates Toby's book.” This book is 313 pages of a garden classic, introducing best practices in gardening — working with mother nature to strengthen and sustain ecosystems in your own backyard. You can get a copy of Gaia's Garden by Toby Hemenway and support the show using the Amazon Link in today's Show Notes for around $17 Today’s Botanic Spark Reviving the little botanic spark in your heart March 15, 1957 It was on this day that the peony became Indiana's fourth state flower. The story of how the peony became selected as the state flower of Indiana is actually rather quite interesting. Apparently, the fine people of Indiana had initially considered the Zinnia for the honor, but when that was struck down, they started talking about the bloom of the redbud. But then that caused a ruckus because people could not figure out whether the redbud was a flower or a tree, or a shrub. This is when a young, distinguished member of the Indiana legislature in Indiana named Lawrence Baker, who happened to be a peony grower, suggested the peony. And that is how the peony ended up on the ballot. Now in 2016, the Daily Journal wrote an excellent article, and it was called “Indiana State Flower has a Colorful Past.”I thought you would get a kick out of it. The Indiana legislature has adjourned for another year. It was a turbulent session. But at least the lawmakers did not have to grapple with the thorny issue of the State Flower. It was March of 1957 that Governor Handley signed a bill, which designated the peony as the official State Flower of Indiana. The act surprised a lot of Hoosier's suddenly uprooted was the reigning State Flower, the Zinnia. What followed was quite a tempest in a flower pot. It is a tale that smells of intrigue, and the garden editor of the Indianapolis Star blamed the flower switch on a “small cult of Zinnia-haters. Perhaps a little history is an order. Every state in the union has an official flower, from the Camillia and Alabama to the Indian Paintbrush in Wyoming. Back home in the Hoosier state. We can't seem to make up our minds. In 1913 we picked the carnation. Ten years later, we favored the tulip tree blossom. Then, in 1931, lawmakers gave the nod to the Zinnia. Motives for these changes seem to be lost in the midst of time. There appears to have been a trade-off in 1931 when we dropped the tulip tree blossom as the state flower. In that same year, the tulip poplar became the official state tree. That probably salved the hurt feelings of tulip blossom fans. Zinnia lovers were caught off guard when the flower switch came in 1957. The director of the Farm Bureau pet and hobby clubs put up a protest. “We have 650 clubs with about 10,000 members,” she complained, “and one of our projects for years has been to provide the children with Zinnia seeds to grow. Imagine the children growing peonies!” Officials at Indiana National Bank already had ordered huge amounts of Zinnia seeds to be given out at the Indianapolis Home Show that year. They could not cancel that order, so they carried on. Now, if you're a Zinnia lover, you'll be happy to know that Indiana's Zinnia fans did not go down without a fight. They began a letter-writing campaign for newspapers all around the state. In fact, a woman named Meredith Haskett felt compelled to wax poetic about the switch. Somehow the men seem quite impelled The Zinnia to discard As Indiana's flower and I think they should be barred. From making further boo-boos; I'd fire them all, perhaps — If I could have my say. I'd probably call them saps For spending time and money To make the Peony queen; She lasts a day or two in the spring — That’s all — no more she’s seen. Indiana is a proud state, Colorful and strong And sturdy as a Zinnia; Somebody’s done her wrong. Thanks for listening to The Daily Gardener. And remember: "For a happy, healthy life, garden every day."
The post “Anger Management” | James 1:19-25 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
Steve Joll speaks with Tabletop Tactics megaboss, Lawrence Baker, about training to be an actor and how that lead to being one of the most watched 40k stars in the world. He tells us how he became the Spider and how they've made it through Covid19. Find Lawrence and the massive library of amazing TT content at tabletoptactics.tv and youtube. 40k Game Changers, with Steve Joll, is a series of conversations with the people who have changed the way we play, paint, collect, and consume Warhammer 40,000. Find out more at www.40kgamechangers.com Join us on facebook. Learn more about your ad choices. Visit megaphone.fm/adchoices
The post Say His Name | Matthew 1:18-25 | Pastor Lawrence Baker appeared first on Faith Community Bible Church.
Dr. Hayes interviews Dr. Lawrence Baker on his early involvement with SWOG ANNOUNCER: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. DANIEL HAYES: Welcome to JCO's Cancer Stories-- The Art of Oncology, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the world of cancer care. You can find all of the shows, including this one, at podcast.asco.org. Today, my guest on the podcast is Dr. Laurence H. "Barry" Baker. Dr. Baker has a long and distinguished career in oncology. It dates back to the early 1970s, when he was intimately involved in new drug development, including doxirubicin or adriamycin, as we know it. He's also led early studies in preoperative chemotherapy in anal cancers. He was instrumental in advances in sarcoma research, and he led the Southwest Oncology Group-- now designated SWOG-- for eight years in the last decade. Dr. Baker was raised in Brooklyn, and since this interview is taking place just a week after the sad loss of Supreme Court Justice Ruth Bader Ginsburg, Dr. Baker informed me that he and his wife Maxine were married in 1964 in the Midwood Jewish Center, Justice Ginsburg's home synagogue. He received his undergraduate degree from the Brooklyn College at the University of New York, and then he graduated from Des Moines University of Osteopathic Medicine in Iowa. He completed a residency in internal medicine at Flint Osteopathic Hospital in Flint, Michigan, and then he has a curious two-year break in his curriculum vitae during which he was on active duty in Vietnam. Upon discharge from the Army, he returned to Michigan, and he served a three year fellowship at Wayne State University, where he stayed on faculty from 1972 to 1994, serving at various times as the chief of the Division of Hematology and Oncology, the chair of the Department of Medicine, and director of the Cancer Center. In 1994, he moved west about 30 miles to Ann Arbor, where he served as the director for the Clinical Research and Translational and Clinical Research Program for the UM Comprehensive Cancer Center, now called the Rogel Cancer Center. And he was also the associate chief of the Division of Hematology and Oncology and currently is the Laurence H. Baker Collegiate Professor in developmental therapeutics. Dr. Baker has authored hundreds of peer-reviewed papers, and like so many of our guests on this program, he has a list of honors that are just, frankly, too long to recite, except two that I want to highlight. He received the ASCO Distinguished Service Award for Scientific Leadership in 2007, and he was named an ASCO Statesman, now designated as a fellow of ASCO in 2010, for his many services to our society. Dr. Baker, welcome to our program. LAURENCE H. BAKER: Thank you. Nice to be here. DANIEL HAYES: Well, it's really great to have you. A lot of questions, but I want to start out, I just can't help but ask you, to be trite, how does a nice boy from Brooklyn end up in the Midwest for the rest of his life? Can you give us some stories about how you got there? LAURENCE H. BAKER: I graduated high school at 15 and went into what some know-- but not everyone knows-- was a very competitive college. Brooklyn College accepted-- was a free school. The grades used in the New York City school system were numerical. They weren't letters. And you had to have a 90 average on high school and certain scores on the state, New York State examinations to get in. And that was it. It didn't matter where your parents went to school. It didn't matter if you had money. And so it was a school largely of relatively low-income families. But that's the one who took me, and I guess they accepted me at 15. To not make this into a long story, but to drag it out a little bit, I was fascinated that I was 15 and I could date 18-year-old girls, and they didn't know it. So that's how I spent the first two years of college. And my grades showed that that was my focus of attention. I did pretty well on the MCAT examination. I would not have gotten into a medical school in this country, and I didn't speak a language that would be sufficient for me to go to Europe, for example, to school. So osteopathy he was where I went. I went to Iowa, but their admitting question to me is, do you have $2,000 a year tuition? To which, of course, I lied. And that's how I ended up being a DO, and that's how I came to the Midwest. And I actually got to like the-- I didn't know anybody from Iowa, as you make reference to my Brooklyn background, but I actually came to really appreciate the Iowa people, and particularly the community people that I came to know. At the time there were-- the really good programs in residency in medicine were in Michigan. That's the direct answer to your question. That's how I came to Michigan. Just about then, just about could have gone to California and gotten an M.D. degree just by taking the licensure examination. And then, that closed. That opportunity closed. So a long story to your question. So I came to Detroit, into Flint, and then returned back to Detroit, and I've been in Michigan ever since. DANIEL HAYES: Now, that raises the second issue I talked about a minute ago. And that is, many of our guests were so-called Yellow Berets at the NIH in the late 1960s and really changed our practice. But you actually ended up in the Evacuation Hospital at Cu Chi in Vietnam. And I've heard horror stories about this. How did that happen? What did you do there? Enlighten me. LAURENCE H. BAKER: Well, there were good and bad things about being an osteopath. The American Osteopathic Association was always in conflict, was always trying to defend itself. And at the time that the Vietnam War was going on, the DOs were not eligible for military service as an officer. You could go in as an enlisted man, but not as an officer. But there was a great need for primary care physicians in Vietnam, and the understanding of the military physicians was that all DOs were primary care physicians. So a deal was struck between the AMA and the Department of Defense that led to the drafting of everyone in my medical school class. Every one of the men-- not women. Every one of the men was drafted. There was a universal draft. I then-- I was given a choice. I could volunteer for the Army or go to jail. Those were the choices. And I had, at the time, two little children with Maxine, and I was not-- you might guess-- not a big fan of the Vietnam War. The alternative was to go to Canada, and I wasn't secure enough to consider that I could actually practice medicine. It was uncertain. So I went in. When I got there, they asked me, did I have any interest in anesthesiology or radiology, because they were really short of those two. And of course, being who I am, I said, if you need a radiologist or an anesthesiologist, why don't you go draft one and let me go home? That didn't work, and so I became-- I was assigned to radiology. DANIEL HAYES: [LAUGHS] LAURENCE H. BAKER: They sent me to Fort Jackson, where-- no, that was actually a good experience then, because I learned a lot about imaging, and I still have interest in imaging, but I don't qualify anymore. This is before CAT scans and MRIs. This is IDPs and upper GIs, right? So anyhow, barium lower bowel examinations. So I was trained for six months, and I stayed on for another few months on staff there and then, lo and behold, was sent to Vietnam. I was sent for a year, but I volunteered to stay an extra month so that I could return without any further obligation to the military and begin my fellowship on July 1, which I had actually secured before I went to Vietnam. So that's the gory details of that. I was elevated to Major about, oh, a few months before I was discharged. And then, because they weren't nasty enough to me when I got home, into my fellowship, I then got a letter congratulating me on being in the active reserve. So I had to go two weeks every summer. That was my summer vacation during fellowship and beginning of faculty. And I had to go once a month for a weekend to play soldier with a bunch of guys who were lucky enough that they didn't have to go to Vietnam. And now we're even, I think. So it was an interesting experience, as I've shared some of it with you. It still is a painful experience in some ways. I was out the busy [INAUDIBLE]. DANIEL HAYES: If you don't mind, a quick story you've told me before about the child with leukemia. LAURENCE H. BAKER: Yes. So they made me a radiologist. I'm not a great-- it doesn't matter where you call me. I am who I am, and I'm really interested in patient care. And there were already five internists, and there was only so much gonorrhea that the troops could acquire. So I volunteered to open a pediatric clinic. And the Army thought that was a good thing for publicity. They did stories about it. Anyway, I opened the clinic for pediatrics. I knew nothing about pediatrics. I mean, the truth is, I had a month of rotation. My wife sent me my textbook. It was Nelson's Textbook of Pediatrics. Nothing I ever saw in Vietnam was ever in Nelson's Textbook. But I did what I could of trying to treat the children as best I could. And along came a young girl, eight years old, who had acute lymphacytic leukemia. I had a wonderful pathologist who was my hoochmate. "Hooch" is translated, there were eight guys who lived in a place. That was called a hooch. And he was a pathologist, and he made the diagnosis of ALL. I had my books from my mentor teaching me about chemotherapy. So even though I hadn't started the fellowship, I had some resources about chemotherapy. And now I had to find chemotherapy. Treated her with-- I started with steroids and penicillin, and then I went to find drugs. I was able to-- I won't tell all the details, but I was able to get drugs at an old French hospital in Saigon. And so I would visit that hospital pretending great interest in the pharmacy, but of course, I stole whatever drug I could steal when the pharmacy wasn't looking. And that included some alkylating agents, methotrexate, 6MP. And so I tell Jay [INAUDIBLE]-- to get to where you want to be, perhaps-- that I invented the bicycle therapy, which was every month, you changed the drug to try to avoid resistance. So that's what I did by necessity. [LAUGHS] And I actually-- there was a second child that I also treated. When I left, they were both in complete remission. And I think that that's what you're asking me. I was lucky that I didn't get shot or thrown in jail for many of these escapades. But I look back and think that at least I did somebody some good. So-- DANIEL HAYES: Kind of makes the current generation who complains about work hours look in a different light, I think. LAURENCE H. BAKER: Yeah, we worked every day. We worked seven days a week with-- there was no such thing as time off. This was the busiest American hospital, certainly in Vietnam, and some think the busiest hospital since the Atlanta train station in the Civil War. It was in Cu Chi, which was on the way to Cambodia, which is, of course, where the North Vietnamese troops would enter into South Vietnam. So it was a major, major place. It was about an hour, an hour and a half west of Saigon. DANIEL HAYES: Let's move on to the rest of your career. You come back, then, and trained at Wayne State, and at the time, [INAUDIBLE]-- and I can never pronounce his name. I'll have you do it. Dr. Venutius Vicevicius-- I always heard him Dr. V.-- who was, I think, a real character and really was one of the first chemotherapy pioneers. Can you tell us more about him? Because we've heard a lot about the folks on the East Coast and the folks in Texas, but not so much what was going on in the middle of the country at the time. LAURENCE H. BAKER: Yeah, Dr. V, or Dr. Vicevicius, who was Lithuanian, he has a story of his life that certainly makes me look like a slump. He was a guest of the Nazis, and then he was a guest of the Russians when Auschwitz was freed. So this was as a child. He grew up in a very educated and somewhat affluent family in Vilnius. And when he got out of these camps, he actually got to medical school in Frankfurt, Goethe Medical School in Frankfurt. He had major interest in biochemistry and, without speaking more than three words of English, chose to come to the United States. And he landed-- I don't really know why; I've heard so many different versions-- but he landed in Detroit and showed up at the Detroit Receiving Hospital-- this would be like LA County or Bellevue in New York, that sort of thing, knife and gun club-- not speaking any English but wanting to do training. And somebody was smart enough to accept him. And so he did his training. He also trained-- after medicine, he trained with Mike Brennan-- that's another name from the past who is a past president of ASCO, by the way, the second or third person, perhaps. Mike was present of the Michigan Cancer Foundation and was the card-carrying medical oncologist in the Detroit area. He trained Dr. V., and he trained another man named Bob Tally, who had a great deal of history to contribute to oncology. And then, V was recruited by Wayne to come there and started a program. He was an extraordinary person. English was the eighth language he learned, and he actually taught me how to write. I flunked college English. I had to take it twice. But he taught me how to write and, I think, made me a better writer. He certainly was an inspiration. His devotion to patients was extraordinary. His knowledge was extraordinary. And so he was a great, great teacher. And one of his major early contributions was the recognition that you could make the drug float-- they had four drugs or five drugs at this time-- but one of them was 5-fluorouracil, that was developed by Fred Ansfield in Minnesota. The drug was given for five days and then every other day until their mouth fell out or their white count got to zero. And maybe that's a little of an exaggeration, but not much. At any rate, he figured out if you gave the drug by continuous infusion-- because it had a rather short half-life-- you could avoid a great deal of the toxicity. And that's how infusion of fluorouracil got its start. He then went on to combine it with other drugs and with radiation, and that was the backbone of this anal canal achievement that you mentioned in the introduction. I had very little to do with it, but I was a cheerleader. It was a rectal surgeon who came to us at the time, and those familiar with that disease-- which we now know is a virus disease that could be prevented, but at that time, nobody had any of that-- the treatment was abdominal perineal resection, and it had to be among the most horrible things we did to people. And the surgeon came to us and said, listen, you guys always squirt those drugs in after they relapse, and I'm really tired of this. Maybe you could give those drugs first, OK? And that's how neoadjuvant chemotherapy got started. It wasn't our idea. It was a surgeon's idea. That story gets repeated again in orthopedics, but that's how it began in anal canal tumors. And so we gave 5FU infusion, and mitomycin, and radiation preoperatively. That almost always shrunk the tumor, by the way-- almost always significantly shrunk the tumor. The patient then once they went through that operation but was cured. And so you took a horrible disease and changed its natural history with that development. If it works once, you know, in oncology, then you try it a second and third time. And I had very shortly thereafter the opportunity to work with a wonderful Japanese pediatric oncologist in Houston, Watsu Tao. He was looking for a partner because he was tired of seeing osteosarcoma patients die. Cure rate at the time was around 20%, 30%, and the surgery that was done for osteosarcoma was amputation, usually of the lower extremities. So 2/3 of osteosarcomas occur around the knee, and the orthopedics really dislike the idea of taking a child's leg off. Every teenager and child wants to be exactly like every other teenager and child, so you can imagine how disruptive it is to have a high amputation of your leg. It took about three months to make a prosthesis, and everyone knew that you didn't really have to do an amputation. You could just cut out the bad bone and replace it with a prosthetic device. But it took three months to make it, because they were handmade at the time. And so the idea came to several people-- Jim Holland was involved in this; Tom Frei was involved in this as well. Different cities were approaching it in this way. And we all ended up giving chemotherapy to these young people-- children, teenagers-- and then having the operation. And osteosarcoma went a cure rate of 20% to 30% to 70% or 80%. And they didn't lose their legs. DANIEL HAYES: I have two personal comments on this. One is you mentioned Dr. Brennan and the Michigan Cancer Foundation. Just for our listeners, Michigan Cancer Foundation is MCF. And if you've done any breast cancer work at all, you've worked with MCF-7 cells or MCF-10 cells [INAUDIBLE], which came from that organization. I think people have forgotten what MCF stands for, except for you and me. LAURENCE H. BAKER: That cell line that you talked about, MCF-7, that was developed by a man with, I think, a high school degree who just had a green thumb at that growing cells-- a wonderful man. And that came from a patient of ours. When I say "ours," I mean Dr. V. I was just the flunky, but it was his patient. And she had ascites from breast cancer. And we would tap ascites, in those days, with some frequency. And the cells for MCF-7 came out of that patient. That's its actual origins, and more papers have been written about MCF-7 than even you and I could count. DANIEL HAYES: Including by me. LAURENCE H. BAKER: I understand. No, it was incredibly useful. I mean, we learned about hormone receptors from this [INAUDIBLE]. DANIEL HAYES: Yep, that's [INAUDIBLE]. LAURENCE H. BAKER: It's was incredible. DANIEL HAYES: My other personal story related to your stories is, as a fellow at the then Sidney Farber Cancer Institute, Dr. Frei was my boss. And he, as you mentioned, was starting to work with Holland and others that had already worked with neoadjuvants. And he would cite your data all the time. Now, I didn't know Larry Baker for us from all the tea in China, but we heard a lot about the Wayne State experience when we were fellows. I don't know if that would have [INAUDIBLE] or not, but people definitely-- LAURENCE H. BAKER: No, I came to SWOG-- which is really why you wanted, I think, to talk to me-- in '70 or '71, I can't remember exactly. And Dr. V, it was an incredible experience. He took me with him. You ran into Tom Frei. They knew each other. And he said, Tom, I want you to meet my colleague, Larry Baker. I just had never been introduced like that. DANIEL HAYES: [LAUGHS] LAURENCE H. BAKER: And Tom was the friendliest person I think I've ever met in oncology. He had a wonderful smile. He clearly-- I was always paranoid that I'm a osteopath. Maybe I went on too long about that story. But when they tell you in school you're just as good as the MDs, you can quickly figure out if you were just as good, they wouldn't keep saying it, right? So that's socially accepted paranoia, and that's how I was brought up. So here is the wonderful, famous Tom Frei being nice to me! I was just amazed. DANIEL HAYES: He used to come to the lunch room in the Dana Farber two or three times a week and would just sit with us, and was constantly thinking of new stuff. This is not an interview with me, but someday, I'd like to tell the stories he told us. He was really just a fabulous man. I want to segway into your work with adriamycin, which is now, of course, also one of the workhorses of oncology. We've all used it. And I believe you were an author on either the first or one of the first phase II trials of adriamycin in Cancer in 1973. Is that an outgrowth of that introduction you just told us? LAURENCE H. BAKER: Yes. That study-- it's in Cancer, I think, not-- I don't think JCO existed. But that study didn't distinguish what the primary was. So it was a phase II study of cancer. And so there was, I don't know, 800 patients. I worked with Bob or Brian on that study. Bob was at Henry Ford, and there was a student of Bob Tally that I had mentioned, and I was the student of V. And the two of us were basically the schleppers for them. And so it had hundreds of patients in it. And in that study, we recognized that it worked in breast cancer, that it worked in lymphoma, and it worked in sarcoma-- and nothing worked in sarcoma. So that was the study. It's often quoted by Jim Dorshow because he said, we do everything that's disease-specific, but look what came out of one study that, by the way, accrued, as I say, 600 or 700 patients in 18 months. And this is before computers, so you can imagine how much work was done to evaluate the flow sheets. It was an incredible opportunity here to work. But it was an amazing paper, and it changed my life, of course. That's how [INAUDIBLE] and other things. DANIEL HAYES: So at the time, you recognized that this was not just another drug off the shelf, that it really was going to be a game-changer? LAURENCE H. BAKER: Absolutely, absolutely. You saw people getting better. And my experiences were mostly in breast cancer patients getting better, and some lymphoma patients that were refractory. First time I saw solid tumor patients dramatically improve. DANIEL HAYES: So I saw that your name is before another giant in the field who was a young Italian investigator who spent time in the United States named Johnny [INAUDIBLE]. LAURENCE H. BAKER: Yeah, that's how I first met him. I don't know that this story's been told. We were trying to make some level of peace with the Russians, and the Russians, of course, claimed that they discovered adriamycin. I don't know, but if you don't know this, I'll continue. DANIEL HAYES: Please go. LAURENCE H. BAKER: OK, but we all-- everyone knew, and certainly [INAUDIBLE] knew, this was an Italian drug, OK? "Adriamycin" is for the Adriatic Sea. As far as I know, you can't see the Adriatic Sea from Russia. But this was a time when our government wanted to be nice. They cared more about building a relationship with the Soviet Union than they did continuing a friendship with the Italians. Jim Holland was then sent to Moscow to negotiate this. That's where the name doxirubicin came from. In other words, we didn't know generic names, trade names. This didn't exist in the early '70s. So we called it adriamycin, which was not only the generic name, it was the trade name, right? Made by adria-- I think far Pharmitalia is the name of the company, right? And as a result of Jim Holland's diplomacy, it became doxirubicin as the generic name. It's a true story. DANIEL HAYES: Yeah. I know that "adria--" came from the Adriatic Sea, but I've not heard that's where "doxi-" came from. That's a good story. That segways into the next segment of your life that fascinates me, and this is your work in SWOG. When I moved here to the University of Michigan, you were on your way to becoming the chair of SWOG, which you did. And it occurred to me that University of Michigan wasn't even in Southwest Michigan, let alone the Southwest of the United States. Just reminisce a little bit about Dr. Coltman, who ran SWOG, the beginnings of SWOG, even before that, and where you see the [INAUDIBLE] groups now. LAURENCE H. BAKER: So Dr. V brought me to a SWOG meeting in San Antonio, Texas, as you said, in 1970 or '71. At the time, Tom Frei was running the group. J. Freireich was chairman of the Leukemia Committee. Chuck Coltman was chairman of the Lymphoma Committee. V specifically chose to work with this group because of those people. You're right, Michigan is not in the Southwest, obviously, and, there were other groups that wanted-- we had a large population of patients we treated, so there was actually some competition, if you will, for us to join other groups. V was adamant that we would be SWOG and that was it, for reasons that I told you. Tom Frei then was invited to go back to Boston. That's how you came to know him. And there was an election for a replacement. And J. Freireich was somebody that we clearly supported. There was no doubt that J. an absolutely brilliant man-- he still is-- and taught a lot of people, trained a lot of people, and taught us a great deal. But he had one flaw. He could not control his ability to saw inappropriate things. If you knew him, you loved him. If you didn't know him, you were like your reaction to the debate, OK? That's how he ground on people. I grew up with the respect for J., as I told you, as I was introduced to him, and he was always incredibly kind to me. Anyway, so we were actively supporting J. To be the replacement. There were some other people that did not want Freireich. So you had some people who didn't have the same feeling. And that's how Boris Hoogstraten became chairman. Boris Hoogstraten was a hematologist from the University of Kansas. And I remember-- and you'll be very proud of me, Dan-- one of my colleagues from Wayne wanted to do a study of this new drug called tamoxifen-- DANIEL HAYES: [LAUGHS] LAURENCE H. BAKER: --for breast cancer, OK? [LAUGHS] And Hoogstraten said, don't you get it, Baker? We're a chemotherapy group. What's with this hormone stuff? I don't have to tell another story, but that one is true. So SWOG didn't study tamoxifen for a long time. Any rate, Boris was an interesting man. I don't want to cut him short. But there came a time when it was clear that SWOG needed to go in a different direction. And we all thought that the right person for that was Chuck Colton. At the time, I have to tell you, there was two things relevant to this. There were lots of regional cooperative groups that don't exist anymore. I led a revolt-- that's what Colton said-- that included the University of Indiana-- Larry Einhorn was in Detroit plotting against Hoogstraten-- along with the University of Michigan. Al Labulio was in Detroit doing that. So you got the idea. So it was a group of institutions, if you want, that were geographically somehow related to the Great Lakes in some way. There were seven or eight of us. And we represented probably 40% of the [INAUDIBLE] of SWOG. And Coltman came to me and said, listen, stay with the group. Don't do this. Stay with the group. And I said, I can't stand this nonsense. I mean, we're not working anymore. We're just-- Anyway, he said, please stay. And he ended up becoming the chairman. And then he turned to me and he said, listen, Larry, I want you to be the deputy. I don't need a title. I don't want a title. He said, no, no, no, I don't care what you need or what you want. I need you right next to me, because if you led a revolt once, I don't want to see it happen again. DANIEL HAYES: [LAUGHS] LAURENCE H. BAKER: Absolutely true story. And so we abandoned the idea of a regional group. I still think that may have been a dynamite group, by the way. But we all stayed-- Indiana was not [INAUDIBLE] SWOG, so let me be clear. That was ECOG, I think. I think that's right. Anyway, so that's how I came to know Chuck, and I was his deputy for 25 years. I had the best job as deputy, because I had nothing to do. He just wanted me sitting there, and that's what we wanted. Then there was some push from the NCI that maybe to 25 years of being chair is a long time, and maybe there's a reason to move on. From that team the suggestion from Bob Livingston and John Crowley, that I was the natural person to do that. I really didn't want it, to be honest. I still maintain that. But there was a good deal of pressure exerted, both from within the group and from the NCI, for me to do that. So I became the chairman, I think, for a couple of terms. I made some changes in the group. I think as groups go on, institutions either get better or they get worse. I think that's true. And we made a number of different ways of appointing disease chairs and things like that, that the group did get better and started on a better path. But I really didn't want to continue it, and there was a time when I was not only running SWOG, but I was also running this sarcoma group called SARC. And it became overwhelming to me. I was working literally 80 hours a week there. So I gave up SARC first. That really-- University of Michigan was thrilled that I did that-- and stayed with SWOG another year or two. But I knew that I wasn't going to stay at that. And so after two terms, I thought I would set the precedent that, maybe, group chairs should have two terms and move on. Witshoski had two two terms. [LAUGHS] But anyway, being serious, I really think there should be a limited amount of time. There's so many talented people in our field that it's silly to think that one person has to stay in these jobs. And so that's-- I think I answered your question. I'm not sure my [INAUDIBLE]. DANIEL HAYES: I have to tell just a brief-- Nobel laureate Bruce Beutler was my intern when I was a resident at UT-Southwestern. After he won the prize, he came up here as a visiting professor, and we went to dinner. And I said, Bruce, I kind of lost track. I know you did an internship with us, but I never heard if you finished your clinical training. And he said, no, I went-- I loved the lab and went back into it. I never did go back and finish my training [INAUDIBLE]. And then he looked at me and said, but I think I worked down all right, don't you? LAURENCE H. BAKER: [LAUGHS] DANIEL HAYES: And in a similar manner, I would say, for all your humility that you've laid out, I think it worked out all right. SWOG is a powerhouse and has changed practice in so many ways. And part of that, a lot of that, was your doing. So we've actually run out of time. I had hoped, actually, to-- you've done too much in your lifetime, Larry. I was hoping to get into the sarcoma work, but we've run out of time. I think everybody who's listening to this who knows about the work you've done in sarcoma-- and lord knows there's plenty of work to do in sarcoma, so-- LAURENCE H. BAKER: Can I give you just one more anecdote, and you can cut it, and I'll try to be very [INAUDIBLE]? DANIEL HAYES: No, no. Please do, please do. LAURENCE H. BAKER: Remember I told you I became chair of the Sarcoma Committee of SWOG? The man I replaced was a man named Jeff Gottlieb. Jeff was a pediatric oncologist-- little did people know-- who was a student of J and Tom at the NCI. Jeff died in his mid-30s of cancer, by the way, but he was the most brilliant medical oncologist I ever met. He was the originator of combination chemotherapy that became popular in breast cancer, and he was involved in sarcomas in combinations as well. I was handpicked by Jeff to be his replacement, which was probably the nicest thing that ever happened to me. And during that period when Jeff died, I went to Houston to his funeral. And I can give you one-sentence description of J. Freireich going to speak at Jeff's funeral. He stood up, and he said, Jeff-- and he broke down and cried for minutes. And that was his talk. When anyone says something to me critical of J. Freireich, I remember that love he showed to his colleague. So that's worth [INAUDIBLE]. DANIEL HAYES: No, that's-- LAURENCE H. BAKER: Not many people were at that funeral. DANIEL HAYES: --very touching. He also gave Dr. Frei's eulogy in Boston, and he got through it, but just barely. It was very similar. These are the kinds of stories I'm hoping to capture in this series. Larry, I'd really like to thank you for taking time to be on. I'd also like to thank you for all you've done for the field, for me personally, frankly, with my time here in Michigan the last 20 years, and most importantly, for our patients who have benefited from all your contributions, your training of-- we could go on about all the people you've trained. So anyway, thanks a lot. We appreciate it. LAURENCE H. BAKER: Thank you. DANIEL HAYES: And have a nice day. LAURENCE H. BAKER: Thank you very much. I appreciate your kind words. DANIEL HAYES: Until next time, thank you for listening to this JCO's Cancer Stories-- The Art of Oncology podcast. If you enjoyed what you heard today, don't forget to give us a rating or review on Apple Podcasts, or wherever you listen. While you're there, be sure to subscribe so you never miss an episode. JCO's Cancer Stories-- The Art of Oncology podcast is just one ASCO's many podcasts. You can find all the shows at podcast.asco.org
The post Can’t Have It Both Ways – Guest Pastor: Lawrence Baker Sr. appeared first on Faith Community Bible Church.
Now that we understand how Lawrence Baker's magical Grey Knight List works we ask how do you use it ? Join Nick Nanavati and John DeMaris as we dive deep into the detail of optimal play with the boys in Grey. Smites for Everyone !! ++ Battalion Detachment +5CP (Imperium – Grey Knights) ++ Armoury of Titan: 1 Additional Relic + HQ + Brother-Captain: Blade of the Forsworn, Edict Imperator, Storm Bolter Nemesis Force Sword: Nemesis Force Sword Librarian: Empyrean Domination, Sanctic Shard, Stormshield (Index), Warp Shaping Nemesis Warding Stave: Nemesis Warding Stave + Troops + Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion ++ Battalion Detachment +5CP (Imperium – Grey Knights) ++ + HQ + Chaplain: 6. Invocation of Focus, Astral Aim, Storm bolter Grand Master Voldus: 6: Lore Master, Armoured Resilience, Ethereal Manipulation, Gate of Infinity, Inner Fire, Warlord + Troops + Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion + Elites + Apothecary: Sanctuary Nemesis Force Halberd: Nemesis Force Halberd Paladin Squad: Hammerhand 9x Paladin (Halberd): 9x Nemesis Force Halberd, 9x Storm Bolter Paragon: Storm Bolter Nemesis Warding Stave: Nemesis Warding Stave Paladin Squad: Hammerhand 5x Paladin (Halberd): 5x Nemesis Force Halberd, 5x Storm Bolter Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paragon: Storm Bolter Nemesis Warding Stave: Nemesis Warding Stave ++ Total: [147 PL, 2,000pts, 2CP] ++ Learn more about your ad choices. Visit megaphone.fm/adchoices
The Great and Powerful OZ from Tabletop Tactics joins us to talk about his recent undefeated record at a 100+ person Tournament. Lawrence Baker breaks down the new Psychic Awakening Grey Knights with Nick Nanavati and John DeMaris. ++ Battalion Detachment +5CP (Imperium – Grey Knights) ++ Armoury of Titan: 1 Additional Relic + HQ + Brother-Captain: Blade of the Forsworn, Edict Imperator, Storm Bolter Nemesis Force Sword: Nemesis Force Sword Librarian: Empyrean Domination, Sanctic Shard, Stormshield (Index), Warp Shaping Nemesis Warding Stave: Nemesis Warding Stave + Troops + Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion ++ Battalion Detachment +5CP (Imperium – Grey Knights) ++ + HQ + Chaplain: 6. Invocation of Focus, Astral Aim, Storm bolter Grand Master Voldus: 6: Lore Master, Armoured Resilience, Ethereal Manipulation, Gate of Infinity, Inner Fire, Warlord + Troops + Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion + Elites + Apothecary: Sanctuary Nemesis Force Halberd: Nemesis Force Halberd Paladin Squad: Hammerhand 9x Paladin (Halberd): 9x Nemesis Force Halberd, 9x Storm Bolter Paragon: Storm Bolter Nemesis Warding Stave: Nemesis Warding Stave Paladin Squad: Hammerhand 5x Paladin (Halberd): 5x Nemesis Force Halberd, 5x Storm Bolter Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paragon: Storm Bolter Nemesis Warding Stave: Nemesis Warding Stave ++ Total: [147 PL, 2,000pts, 2CP] ++ Learn more about your ad choices. Visit megaphone.fm/adchoices
Now that we understand how Lawrence Baker's magical Grey Knight List works we ask how do you use it ? Join Nick Nanavati and John DeMaris as we dive deep into the detail of optimal play with the boys in Grey. Smites for Everyone !! Find us on Facebook ! Join our Patreon ! ++ Battalion Detachment +5CP (Imperium – Grey Knights) ++ Armoury of Titan: 1 Additional Relic + HQ + Brother-Captain: Blade of the Forsworn, Edict Imperator, Storm Bolter Nemesis Force Sword: Nemesis Force Sword Librarian: Empyrean Domination, Sanctic Shard, Stormshield (Index), Warp Shaping Nemesis Warding Stave: Nemesis Warding Stave + Troops + Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion ++ Battalion Detachment +5CP (Imperium – Grey Knights) ++ + HQ + Chaplain: 6. Invocation of Focus, Astral Aim, Storm bolter Grand Master Voldus: 6: Lore Master, Armoured Resilience, Ethereal Manipulation, Gate of Infinity, Inner Fire, Warlord + Troops + Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion + Elites + Apothecary: Sanctuary Nemesis Force Halberd: Nemesis Force Halberd Paladin Squad: Hammerhand 9x Paladin (Halberd): 9x Nemesis Force Halberd, 9x Storm Bolter Paragon: Storm Bolter Nemesis Warding Stave: Nemesis Warding Stave Paladin Squad: Hammerhand 5x Paladin (Halberd): 5x Nemesis Force Halberd, 5x Storm Bolter Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paragon: Storm Bolter Nemesis Warding Stave: Nemesis Warding Stave ++ Total: [147 PL, 2,000pts, 2CP] ++ Learn more about your ad choices. Visit megaphone.fm/adchoices
The Great and Powerful OZ from Tabletop Tactics joins us to talk about his recent undefeated record at a 100+ person Tournament. Lawrence Baker breaks down the new Psychic Awakening Grey Knights with Nick Nanavati and John DeMaris. Find us on Facebook ! Join our Patreon ! ++ Battalion Detachment +5CP (Imperium – Grey Knights) ++ Armoury of Titan: 1 Additional Relic + HQ + Brother-Captain: Blade of the Forsworn, Edict Imperator, Storm Bolter Nemesis Force Sword: Nemesis Force Sword Librarian: Empyrean Domination, Sanctic Shard, Stormshield (Index), Warp Shaping Nemesis Warding Stave: Nemesis Warding Stave + Troops + Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Gate of Infinity 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion ++ Battalion Detachment +5CP (Imperium – Grey Knights) ++ + HQ + Chaplain: 6. Invocation of Focus, Astral Aim, Storm bolter Grand Master Voldus: 6: Lore Master, Armoured Resilience, Ethereal Manipulation, Gate of Infinity, Inner Fire, Warlord + Troops + Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion Strike Squad: Vortex of Doom 4x Grey Knight (Falchions): 8x Nemesis Falchion, 4x Storm Bolter Grey Knight Justicar: Storm bolter Nemesis Falchion: 2x Nemesis Falchion + Elites + Apothecary: Sanctuary Nemesis Force Halberd: Nemesis Force Halberd Paladin Squad: Hammerhand 9x Paladin (Halberd): 9x Nemesis Force Halberd, 9x Storm Bolter Paragon: Storm Bolter Nemesis Warding Stave: Nemesis Warding Stave Paladin Squad: Hammerhand 5x Paladin (Halberd): 5x Nemesis Force Halberd, 5x Storm Bolter Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paladin (Psycannon): Psycannon (Terminator) Nemesis Force Halberd: Nemesis Force Halberd Paragon: Storm Bolter Nemesis Warding Stave: Nemesis Warding Stave ++ Total: [147 PL, 2,000pts, 2CP] ++ Learn more about your ad choices. Visit megaphone.fm/adchoices
40K Stats Centre: Nice Guy Finishes Second - Interview with Lawrence Baker and his 6-0 Grey Knights Download or Subscribe to the Podcast: https://bit.ly/33Z7fNT Youtube Playlist: https://bit.ly/2RqsXaE Twitch! https://www.twitch.tv/40kstatscentre 5:48 Falcon breaks down how much better the ITC top 100 players were at the LVO 18:09 Cancontent - we speak with Liam Hackett and Chris Wright from the Australian Championships 41:30 A Gentlemanly and sporting Brawl at the Beach was held. We get the scoop from Vik and THE Lawrence Baker. 1:12:36 The Wheat City Open proves once again that Brandon Manitoba is on a map. And winner Cyle Thompson proves that they have maps in North Dakota by showing up and winning. 01:20:53 The quickest hitters that have ever been hit quickly. Shoutout www.frontlinegaming.org for all your gaming needs. Wanna help out folks integral to the show? Then check out this veritable smorgasbord of Patreon options! www.patreon.com/40kstats www.patreon.com/ITCSupporters www.patreon.com/chaptertactics Learn more about your ad choices. Visit megaphone.fm/adchoices
With Petey Pab, Geoff and Sean distracted - Val takes the opportunity to highjack the podcast. He dials up internet friend Lawrence Baker from Tabletop Tactics, and the two yammer on about Adepticon and No Retreat 6 until the authorities arrive. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode, we talk with Lawrence Baker who runs the website and YouTube channel Tabletop Tactics. We discuss some of the current topics in 40K, including the pace of changes from GW and how to speed up games at... The post Episode 59: Interview with Lawrence from Tabletop Tactics appeared first on TheBattlehosts.
Carrie Culberson. August 28, 1996. Blanchester, Ohio. 22 year old Carrie Culberson arrived at her home very late in the evening after playing volleyball. Then she and her car just vanished. Or seemed to, anyway. A neighbor said that she witnessed the young woman's boyfriend, Vincent Doan, hitting her and heard him say, 'I told you if you ever tried to leave me I'd kill you'. Carrie's family tried their best to search for her, but the most promising lead developed when two dogs both alerted by a pond on the property of Lawrence Baker who was Doan's father. Detectives felt that this was significant and thought that answers to Carrie's whereabouts were about to be revealed. But before the pond could be drained and searched, someone put a stop to it and dealt a serious blow to the investigation...
Episode 3 – Eighth Edition Rules Review with Lawrence Baker We are joined by friend of the show, Lawrence Baker,… --- Send in a voice message: https://anchor.fm/aoti40k/message
Welcome to a new style of show. Darren interviews Lawrence from Table Top Tactics. Listen and as usual: Enjoy, Email: canhammer.podcast@gmail.com Twitter: @CanHammerChris @CanHammerYT @CanHammerLogan Itunes: CanHammer YouTube: https://www.youtube.com/canhammer Instagram: https://www.instagram.com/canhammer_yt/
Lawrence Baker presents on Alvaro Obregon.
Lawrence Baker, Chief of Health Services Research at Stanford University, discusses the ways capacity and structure of the health care system influence health outcomes and spending. (October 24, 2009)